Skip Navigation

Obesity - orlistat (replaced by CG43)

Orlistat for the treatment of obesity in adults

Guidance type:  Technology appraisal
Date issued:  March 2001

We will consult on our review plans for this guidance in February 2004.
Reference:  TA22

Summary

This guidance is obsolete and has been replaced by CG43 Obesity.
Top

Documents

For healthcare professionals

  • None found

For patients, carers and the public

  • None found

Background information

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

  • None found
Top

Search NICE guidance


Advanced guidance search

Related information

See NICE guidance in practice

Related guidance

Click the links below to see guidance on similar topics

Order NICE guidance

Order printed copies of our guidance